-       Report 
- April 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- October 2025
-  373 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
            -       Report 
- August 2024
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
      €4338EUR$4,850USD£3,816GBP 
          -       Report 
- March 2023
-  9 Pages 
- Global 
   From       €2818EUR$3,150USD£2,478GBP 
             Oncology Ablation is a medical procedure used to treat cancer by destroying or removing cancerous tissue. It is used to treat tumors that are too small or too deep to be treated with surgery, or when surgery is not an option. Ablation can be used to treat a variety of cancers, including liver, kidney, lung, and prostate cancer. It is also used to treat some types of brain tumors. Ablation is typically performed using either radiofrequency ablation (RFA) or microwave ablation (MWA). RFA uses    high-frequency radio waves to heat and destroy cancer cells, while MWA uses microwaves to heat and destroy cancer cells.
The Oncology Ablation market is a rapidly growing segment of the Oncology Drugs market. It is driven by the increasing prevalence of cancer, the development of new technologies, and the increasing demand for minimally invasive treatments. Companies in the Oncology Ablation market include AngioDynamics, Boston Scientific, Medtronic, Stryker, and Smith & Nephew. Show Less   Read more